NCT03971123 - Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

April 2, 2020

Study Completion Date

May 26, 2020

Conditions

Alzheimer Disease

Interventions

DRUG

Tricaprilin

Tricaprilin formulated as AC-SD-03 50g of AC-SD-03 (20g tricaprilin) mixed in 240mL dosing liquid at Hour 0 Day 1

DRUG

Tricaprilin

Tricaprilin formulated as AC-LMP-01 50g of AC-LMP-01 (20g tricaprilin) mixed in 240mL dosing liquid at Hour 0 Day 1

DRUG

Placebo

Matching placebo to AC-SD-03 50g of AC-SD-03P mixed in 240mL dosing liquid at Hour 0 Day 1

DRUG

Tricaprilin

Tricaprilin formulated as AC-1202 60g of AC-1202 (20g caprlic triglyceride) mixed in 240mL dosing liquid at Hour 0 Day 1

Trial Locations (1)

Nucleus Network, Melbourne